In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis.
Tomita N, Morishita R, Lan HY, Yamamoto K, Hashizume M, Notake M, Toyosawa K, Fujitani B, Mu W, Nikolic-Paterson DJ, Atkins RC, Kaneda Y, Higaki J, Ogihara T.
Tomita N, et al. Among authors: mu w.
J Am Soc Nephrol. 2000 Jul;11(7):1244-1252. doi: 10.1681/ASN.V1171244.
J Am Soc Nephrol. 2000.
PMID: 10864580